mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0002 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0002 |